Under Questioning From Chairwoman Maloney, Emergent CEO Admits Executives Sold Stock Before Public Learned of Vaccine Problems
May 20, 2021
May 20, 2021
WASHINGTON, May 20 -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following news release on May 19, 2021:
At today's Select Subcommittee on the Coronavirus Crisis hearing examining Emergent Biosolutions's multi-million-dollar contracts to produce vaccines, Oversight and Reform Committee Chairwoman Carolyn B. Maloney questioned Emergent's CEO Robert Kramer. Mr. Kramer admitted under questioning that the United States has been unable . . .
At today's Select Subcommittee on the Coronavirus Crisis hearing examining Emergent Biosolutions's multi-million-dollar contracts to produce vaccines, Oversight and Reform Committee Chairwoman Carolyn B. Maloney questioned Emergent's CEO Robert Kramer. Mr. Kramer admitted under questioning that the United States has been unable . . .